BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11585822)

  • 1. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling.
    Ushio-Fukai M; Hilenski L; Santanam N; Becker PL; Ma Y; Griendling KK; Alexander RW
    J Biol Chem; 2001 Dec; 276(51):48269-75. PubMed ID: 11585822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.
    Ushio-Fukai M; Zuo L; Ikeda S; Tojo T; Patrushev NA; Alexander RW
    Circ Res; 2005 Oct; 97(8):829-36. PubMed ID: 16151024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells.
    Ushio-Fukai M; Griendling KK; Becker PL; Hilenski L; Halleran S; Alexander RW
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):489-95. PubMed ID: 11304462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control.
    Parpal S; Karlsson M; Thorn H; Strålfors P
    J Biol Chem; 2001 Mar; 276(13):9670-8. PubMed ID: 11121405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy.
    Zuo L; Ushio-Fukai M; Ikeda S; Hilenski L; Patrushev N; Alexander RW
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1824-30. PubMed ID: 15976327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II.
    Takaguri A; Shirai H; Kimura K; Hinoki A; Eguchi K; Carlile-Klusacek M; Yang B; Rizzo V; Eguchi S
    J Mol Cell Cardiol; 2011 Mar; 50(3):545-51. PubMed ID: 21172357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubules regulate angiotensin II type 1 receptor and Rac1 localization in caveolae/lipid rafts: role in redox signaling.
    Zuo L; Ushio-Fukai M; Hilenski LL; Alexander RW
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1223-8. PubMed ID: 15142861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2.
    Haider UG; Roos TU; Kontaridis MI; Neel BG; Sorescu D; Griendling KK; Vollmar AM; Dirsch VM
    Mol Pharmacol; 2005 Jul; 68(1):41-8. PubMed ID: 15849355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
    Akhtar S; Yousif MH; Dhaunsi GS; Chandrasekhar B; Al-Farsi O; Benter IF
    Br J Pharmacol; 2012 Mar; 165(5):1390-400. PubMed ID: 21806601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt.
    Eguchi S; Iwasaki H; Ueno H; Frank GD; Motley ED; Eguchi K; Marumo F; Hirata Y; Inagami T
    J Biol Chem; 1999 Dec; 274(52):36843-51. PubMed ID: 10601235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities.
    Couet J; Sargiacomo M; Lisanti MP
    J Biol Chem; 1997 Nov; 272(48):30429-38. PubMed ID: 9374534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor transactivation in angiotensin II-induced signaling: role of cholesterol-rich microdomains.
    Shah BH
    Trends Endocrinol Metab; 2002; 13(1):1-2. PubMed ID: 11750852
    [No Abstract]   [Full Text] [Related]  

  • 13. Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors.
    Olivares-Reyes JA; Shah BH; Hernández-Aranda J; García-Caballero A; Farshori MP; García-Sáinz JA; Catt KJ
    Mol Pharmacol; 2005 Aug; 68(2):356-64. PubMed ID: 15905421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor.
    Murasawa S; Mori Y; Nozawa Y; Gotoh N; Shibuya M; Masaki H; Maruyama K; Tsutsumi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Iwasaka T; Inada M; Matsubara H
    Circ Res; 1998 Jun; 82(12):1338-48. PubMed ID: 9648731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats.
    Touyz RM; Wu XH; He G; Salomon S; Schiffrin EL
    Hypertension; 2002 Feb; 39(2 Pt 2):479-85. PubMed ID: 11882594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo.
    Sedding DG; Hermsen J; Seay U; Eickelberg O; Kummer W; Schwencke C; Strasser RH; Tillmanns H; Braun-Dullaeus RC
    Circ Res; 2005 Apr; 96(6):635-42. PubMed ID: 15731459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Eguchi S; Numaguchi K; Iwasaki H; Matsumoto T; Yamakawa T; Utsunomiya H; Motley ED; Kawakatsu H; Owada KM; Hirata Y; Marumo F; Inagami T
    J Biol Chem; 1998 Apr; 273(15):8890-6. PubMed ID: 9535870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction.
    Hua H; Munk S; Whiteside CI
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F303-12. PubMed ID: 12388423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.
    Yang X; Zhu MJ; Sreejayan N; Ren J; Du M
    Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.